Clinical Trial Update: Effect of Nicorandil in Type 2 Diabetic Obese Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating nicorandil for patients with Type 2 diabetes mellitus and obesity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Nicorandil (nicorandil)

Snippet

Sponsor: Tanta University | Conditions: Diabetes Mellitus, Type 2 | Phase 2, Phase 3 | Status: RECRUITING